Lecture 31
1. Damage-Response Framework
Purpose: This model explains microbial pathogenesis as a balance between pathogen virulence and host response.
Trade-Offs: Pathogens must balance host exploitation with transmission potential; too much damage can reduce host survival, impacting pathogen spread.
2. Evolution of Bacterial Pathogens
Selection Pressure: Pathogens face natural selection pressures, with mutations that enhance survival being favored.
Patho-Adaptation: Bacteria can acquire virulence factors quickly through:
High Mutation Rates: Bacterial replication enzymes are error-prone, increasing mutation rates.
Horizontal Gene Transfer (HGT): Acquisition of genes from other bacteria, often via:
Transformation: Uptake of environmental DNA.
Pathogenicity Islands (PAIs): Large gene clusters gained through HGT that provide new pathogenic traits (e.g., Salmonella SPI-1 and SPI-2 islands for host invasion and survival).
3. Evolution of Viral Pathogens
High Mutation Rates:
RNA viruses, such as HIV and Influenza, have error-prone replication enzymes (e.g., reverse transcriptase), leading to rapid genetic changes.
Mutation rates vary:
HIV: ~1 mutation every 7,000 base pairs.
Norovirus: ~1 mutation per genome replication cycle.
Rapid Replication: Viruses replicate within hours, creating large populations quickly, allowing rapid mutation accumulation and evolution.
Gene Swapping (HGT): Viruses infecting the same cell can exchange genetic material, as seen in influenza, which can result in major antigenic changes and contribute to pandemics.
4. Antigenic Drift vs. Antigenic Shift
Antigenic Drift: Gradual mutations in viral antigens (common in influenza), leading to reduced immune recognition over time.
Antigenic Shift: Major genetic recombination events (often due to HGT), resulting in new viral strains that can cause widespread outbreaks.
5. Immune System Adaptation to Pathogen Evolution
VDJ Recombination: This process in immune cells generates a diverse array of antibodies and T-cell receptors, allowing the immune system to recognize a vast number of pathogens.
Therapeutics: Advances in understanding pathogen evolution guide vaccine and antiviral development to stay ahead of rapidly evolving pathogens.